CMN-005 by CoImmune for Nodal Marginal Zone B-Cell Lymphoma: Likelihood of Approval

CMN-005 is under clinical development by CoImmune and currently in Phase II for Nodal Marginal Zone B-Cell Lymphoma.

Novel CAR-T for Glioblastoma Induced ‘Dramatic’ Responses in Early Trial

A new approach to chimeric antigen receptor (CAR) T-cell therapy showed promise in treating recurrent glioblastoma, according to a small phase I study. In the

March 14, 2024

Timing of nocturnal hot flashes may impact heart disease risk

Nocturnal hot flashes are disruptive regardless of when they occur during the night. A new study suggests that more hot flashes occur during the second

September 10, 2024

Talkdesk Copilot Embedded in Epic Cheers CRM

What You Should Know: – Talkdesk, a provider of AI-powered customer experience (CX) solutions, recently announced the integration of its Talkdesk Copilot with Epic’s Cheers

August 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.